Abbott (NYSE: ABT) has reported new data supporting its Tendyne transcatheter mitral valve replacement (TMVR) system.

LUXEMBOURG / ACCESSWIRE / February 3, 2020 / Jean Boulle Medtech Ltd. (the "Company"), founder of Tendyne Holdings, Inc. ("Tendyne") and a Jean Boulle Group (the "Group") company developing medical ...

Abbott Laboratories ABT recently received Food and Drug Administration (“FDA”) approval for its Tendyne transcatheter mitral valve replacement (TMVR) system. The Tendyne system replaces mitral valves ...

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

SAN FRANCISCO -- Operators had a favorable early experience using the Tendyne transcatheter mitral valve replacement (TMVR) system for severe mitral regurgitation (MR) and mitral annular calcification ...

Two-year outcomes following transcatheter mitral valve replacement with the Tendyne prosthesis showed durable control of mitral regurgitation, sustained improvement in quality of life and functional ...

Minneapolis Heart Institute Foundation is the first research center in the USA to report implant of a TMVR Device ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne") a privately held clinical stage ...

Boise, Idaho-based Saint Alphonsus Regional Medical Center became the first in the state to perform a Tendyne mitral valve replacement, the Daily Fly reported Dec. 7. The device is inserted through a ...

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...

ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company, announced today that the Tendyne Transcatheter Mitral Valve system has been successfully ...

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

- First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option As the most common heart disease affecting the heart valves, MR ...